Search

everythinglearnresearchcommunity

for

Search:↓

New hair regrowth model introduced, imiquimod kills skin cancer cells, T-cadherin loss makes skin cancer more invasive, no strong link between PTCH1 gene and skin cancer after transplant, and male teens more likely to have hereditary hair loss.

Retinoids or their analogs could treat skin pigmentation disorders like melasma and vitiligo.

Blocking CD44 can reduce leukocyte migration in autoimmune skin diseases.

TIP39 and PTH2R help control calcium levels and skin cell development.

CD1d expression in scalp skin and hair follicles changes with the hair cycle and may help protect against microbes.

The study created a mouse model to better understand hair follicle stem cells' role in hair growth and repair.

Vitiligo and alopecia areata may have similar causes despite their differences.

CTCL patients can safely continue treatment during COVID-19 with proper safety measures.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

CS12192 effectively treats alopecia areata with better safety than current options.

Anti-TNF therapy can cause a rare hair loss condition similar to alopecia areata.

BST2 is a key marker for hair loss disease alopecia areata.

LONRF1 is important for oxidative damage response and tissue remodeling during wound healing.

Tofacitinib effectively and safely promotes hair regrowth in alopecia patients.

Two mouse mutations cause similar hair loss despite different skin changes.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

High levels of ODC and a mutant Ha-ras gene cause tumors in mice.

Controlled microflora in animals delays immune cell maturation and affects immunity.

Certain microRNAs may help treat alopecia areata by targeting immune pathways.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

Hinokitiol may help treat hair loss by reducing inflammation and promoting hair growth.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

IL-27 may help prevent hair loss by creating immune-suppressing cells.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

Tofacitinib helped a woman regrow hair with no major side effects.

K10 may not prevent tumors as previously thought and might increase benign tumor risk.